AstraZeneca Escapes Nexium False Ad Suit
The health care funds of six New York-based unions cannot pursue a class action accusing AstraZeneca Pharmaceuticals LP of running a deceptive marketing campaign for the heartburn drug Nexium after a...To view the full article, register now.
Already a subscriber? Click here to view full article